Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
4(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
13%
Ph phase_3
3
38%
Ph phase_2
3
38%
Ph phase_4
1
13%

Phase Distribution

1

Early Stage

3

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
3(37.5%)
Phase 3Large-scale testing
3(37.5%)
Phase 4Post-market surveillance
1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

8

all time

Status Distribution
Active(7)
Completed(1)

Detailed Status

Recruiting4
Not yet recruiting3
Completed1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (12.5%)
Phase 23 (37.5%)
Phase 33 (37.5%)
Phase 41 (12.5%)

Trials by Status

recruiting450%
completed113%
not_yet_recruiting338%

Recent Activity

4 active trials
Showing 5 of 8
recruitingphase_3

A PAN-USR TB Multi-Center Trial

NCT06905522
recruitingphase_4

Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease

NCT07213765
recruitingphase_2

PanACEA - STEP2C -01

NCT05807399
recruitingphase_2

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

NCT06114628
not_yet_recruitingphase_3

Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)

NCT07163143
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06905522Phase 3

A PAN-USR TB Multi-Center Trial

Recruiting
NCT07213765Phase 4

Short-term Antibiotic Therapy in Mycobacterium Avium Complex Pulmonary Disease

Recruiting
NCT05807399Phase 2

PanACEA - STEP2C -01

Recruiting
NCT06114628Phase 2

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

Recruiting
NCT07163143Phase 3

Optimal Treatment Duration for Radiographically Apparent, Bacteriologically Unconfirmed TB, Identified Through Active Case Finding (RADIO-TB Trial)

Not Yet Recruiting
NCT07129629Phase 2

Short-Course Regimen With Bedaquiline, Moxifloxacin and Pyrazinamide for Early Bactericidal Activity in Drug-Susceptible Tuberculosis

Not Yet Recruiting
NCT07076225Phase 3

Ultra-Short Regimen for Elderly DS-TB

Not Yet Recruiting
NCT02457208Phase 1

PK Study of Anti-TB Drugs

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8